Syndax Pharmaceuticals, Inc. (SNDX)
NASDAQ: SNDX · Real-Time Price · USD
22.29
-0.51 (-2.24%)
At close: Jul 20, 2026, 4:00 PM EDT
22.19
-0.10 (-0.47%)
After-hours: Jul 20, 2026, 7:34 PM EDT

Syndax Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,9751,8361,1331,8331,7331,204
Market Cap Growth
148.16%62.10%-38.20%5.75%44.02%13.03%
Enterprise Value
1,9591,424552.031,2571,250777.72
Last Close Price
22.2921.0113.2221.6125.4521.89
PE Ratio
-----47.59
PS Ratio
9.0910.6547.84--8.61
PB Ratio
47.4228.413.933.313.712.95
P/TBV Ratio
46.6728.163.932.743.312.87
P/FCF Ratio
-----41.50
P/OCF Ratio
-----41.32
EV/Sales Ratio
9.028.2623.31--5.57
EV/EBITDA Ratio
-----29.61
EV/EBIT Ratio
-----29.66
EV/FCF Ratio
-----26.82
Debt / Equity Ratio
0.020.020.010.000.000.05
Debt / EBITDA Ratio
-----0.80
Debt / FCF Ratio
-----0.72
Net Debt / Equity Ratio
-8.65-6.38-2.02-1.04-1.03-1.04
Net Debt / EBITDA Ratio
1.611.511.712.513.19-16.21
Net Debt / FCF Ratio
1.291.272.113.593.62-14.68
Asset Turnover
0.430.270.04000.37
Inventory Turnover
0.260.424.51---
Quick Ratio
4.884.015.749.9416.7921.60
Current Ratio
5.474.405.8210.0016.8521.68
Return on Equity (ROE)
-457.87%-161.82%-75.69%-40.98%-34.10%7.55%
Return on Assets (ROA)
-44.60%-43.54%-50.78%-41.43%-32.05%6.99%
Return on Invested Capital (ROIC)
-1605.81%-439.27%-437.47%-1123.37%-3190.85%877.95%
Return on Capital Employed (ROCE)
-56.16%-52.98%-57.76%-44.96%-33.83%7.38%
Earnings Yield
-----2.10%
FCF Yield
-----2.41%
Buyback Yield / Dilution
-1.50%-1.17%-21.67%-15.82%-13.31%-29.81%
Total Shareholder Return
-1.50%-1.17%-21.67%-15.82%-13.31%-29.81%
SEC Filings: 10-K · 10-Q